Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin for chronic GVHD prophylaxis in HLA-matched sibling stem cell transplantation for acute leukemia
KCT0002291Phase 3Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Apr 2017
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin in Acute Leukaemia, sponsored by Seoul St. Mary's Hospital. Started Apr 2017; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on KCT0002291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002291.